{"nct_id":"NCT00386139","title":"A Safety and Efficacy Trial of the Combination of Aliskiren / Hydrochlorothiazide (HCTZ)(300/12.5 mg and 300/25 mg) Compared to Aliskiren 300 mg in Hypertensive Patients","status":"COMPLETED","status_verified_date":"2017-02","start_date":"2006-09","start_date_type":null,"primary_completion_date":"2007-07","primary_completion_date_type":"ACTUAL","completion_date":"2007-07","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}